doi: 10.1038/nri2171 7 AmersfoortJEelenGCarmelietP
**Product contains benzyl alcohol as an inactive ingredient Contraindications for Benzyl Alcohol This preparation is not advised in patients who are sensitive to cobalt and/or vitamin B12
Frequency Use once daily, preferably in the evening
Are you struggling with constant fatigue, low energy, or difficulty staying focused throughout the day
Disclosure of interest: Nothing to disclose Poster Session I - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.02 - SECONDARY PREVENTION P412 - ESOC25-2081 THE CURRENT STATUS, DECISION MAKING AND EFFECTIVENESS OF DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ISCHEMIC STROKE IN CHINA Xiaoqing Jiang 1 , Zixiao Li 1,2,3 , Yongjun Wang 1,2,3 1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China, 2 China National Clinical Research Center for Neurological Diseases, Beijing, China, 3 National Center for Healthcare Quality Management in Neurological Diseases, Beijing, China Background and Aims: In real-world settings, the application scope of dual antiplatelet therapy (DAPT) for acute ischemic stroke (AIS) is more extensive than that of randomized controlled trials (RCTs)
Minoxidil and finasteride are FDA-approved for pattern hair loss on the basis of multiple controlled human trials, with well-characterized (if modest) benefits
